168 related articles for article (PubMed ID: 32368809)
1. Palladium(II)-η
Scattolin T; Bortolamiol E; Visentin F; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Togni A
Chemistry; 2020 Sep; 26(51):11868-11876. PubMed ID: 32368809
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell lines.
Scattolin T; Caligiuri I; Canovese L; Demitri N; Gambari R; Lampronti I; Rizzolio F; Santo C; Visentin F
Dalton Trans; 2018 Oct; 47(38):13616-13630. PubMed ID: 30207339
[TBL] [Abstract][Full Text] [Related]
3. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
[TBL] [Abstract][Full Text] [Related]
4. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer.
Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F
Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011
[TBL] [Abstract][Full Text] [Related]
5. Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression.
Fong TT; Lok CN; Chung CY; Fung YM; Chow PK; Wan PK; Che CM
Angew Chem Int Ed Engl; 2016 Sep; 55(39):11935-9. PubMed ID: 27571430
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands.
Scattolin T; Caligiuri I; Mouawad N; El Boustani M; Demitri N; Rizzolio F; Visentin F
Eur J Med Chem; 2019 Oct; 179():325-334. PubMed ID: 31255929
[TBL] [Abstract][Full Text] [Related]
7. Palladium(ii) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors.
Oliveira CG; Romero-Canelón I; Silva MM; Coverdale JPC; Maia PIS; Batista AA; Castelli S; Desideri A; Sadler PJ; Deflon VM
Dalton Trans; 2019 Nov; 48(44):16509-16517. PubMed ID: 31670343
[TBL] [Abstract][Full Text] [Related]
8. Platinum(0)-η
Compagno N; Piccolo R; Bortolamiol E; Demitri N; Rizzolio F; Visentin F; Scattolin T
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474631
[TBL] [Abstract][Full Text] [Related]
9. Metal-(Acyclic Diaminocarbene) Complexes Demonstrate Nanomolar Antiproliferative Activity against Triple-Negative Breast Cancer.
Katkova SA; Bunev AS; Gasanov RE; Khochenkov DA; Kulsha AV; Ivashkevich OA; Serebryanskaya TV; Kinzhalov MA
Chemistry; 2024 May; 30(28):e202400101. PubMed ID: 38363795
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the promising anticancer activity of palladium(II)-aryl complexes bearing diphosphine ligands: a structure-activity relationship analysis.
Tonon G; Mauceri M; Cavarzerani E; Piccolo R; Santo C; Demitri N; Orian L; Nogara PA; Rocha JBT; Canzonieri V; Rizzolio F; Visentin F; Scattolin T
Dalton Trans; 2024 May; 53(19):8463-8477. PubMed ID: 38686752
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
[TBL] [Abstract][Full Text] [Related]
12. Rational Design of Palladium(II) Indenyl and Allyl Complexes Bearing Phosphine and Isocyanide Ancillary Ligands with Promising Antitumor Activity.
Bortolamiol E; Botter E; Cavarzerani E; Mauceri M; Demitri N; Rizzolio F; Visentin F; Scattolin T
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257258
[TBL] [Abstract][Full Text] [Related]
13. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
Matesanz AI; Leitao I; Souza P
J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
[TBL] [Abstract][Full Text] [Related]
14. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study.
Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z
Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417
[TBL] [Abstract][Full Text] [Related]
15. trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
Guerrero E; Miranda S; Lüttenberg S; Fröhlich N; Koenen JM; Mohr F; Cerrada E; Laguna M; Mendía A
Inorg Chem; 2013 Jun; 52(11):6635-47. PubMed ID: 23692403
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Anticancer Evaluation and Synergistic Effects with cisplatin of Novel Palladium Complexes: DNA, BSA Interactions and Molecular Docking Study.
Joksimović N; Janković N; Petronijević J; Baskić D; Popovic S; Todorović D; Zarić M; Klisurić O; Vraneš M; Tot A; Bugarčić Z
Med Chem; 2020; 16(1):78-92. PubMed ID: 30686264
[TBL] [Abstract][Full Text] [Related]
17. The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines.
Marverti G; Gozzi G; Lauriola A; Ponterini G; Belluti S; Imbriano C; Costi MP; D'Arca D
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817267
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, anti-tumor effects and structure-activity relationships of nickel and palladium S,C,S pincer complexes against double and triple-positive and triple-negative breast cancer (TNBC) cells.
Hosseini-Kharat M; Rahimi R; Alizadeh AM; Zargarian D; Khalighfard S; Mangin LP; Mahigir N; Ayati SH; Momtazi-Borojeni AA
Bioorg Med Chem Lett; 2021 Jul; 43():128107. PubMed ID: 33991624
[TBL] [Abstract][Full Text] [Related]
19. Mixed natural arylolefin-quinoline platinum(II) complexes: synthesis, structural characterization and in vitro cytotoxicity studies.
Chi NTT; Thong PV; Mai TTC; Van Meervelt L
Acta Crystallogr C Struct Chem; 2018 Dec; 74(Pt 12):1732-1743. PubMed ID: 30516159
[TBL] [Abstract][Full Text] [Related]
20. Comparative anti-proliferative activity of some new 2-(arylazo)phenolate-palladium (II) complexes and cisplatin against some human cancer cell lines.
Banerjee P; Majumder P; Halder S; Drew MG; Bhattacharya S; Mazumder S
Free Radic Res; 2015 Mar; 49(3):253-68. PubMed ID: 25564263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
